ILD-associated blood biomarkers such as ferritin, Krebs von den Lungen-6 (KL-6), surfactant protein-D (SP-D) and cytokines can provide information on disease presence, activity, treatment response, and prognosis [20]. The gene discussed is SFTPD; the disease is interstitial lung disease.